INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS

This adverse event was reported 5448 times

These drugs are most commonly taken by patients reporting INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS:

# Drug Count
0 DORNASE ALFA 2316
1 TOBRAMYCIN 1580
2 LUMACAFTOR AND IVACAFTOR 1462
3 PANCRELIPASE 1326
4 TEZACAFTOR AND IVACAFTOR 1183
5 ALBUTEROL SULFATE 966
6 AZTREONAM 851
7 ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR 823
8 SODIUM CHLORIDE 802
9 SODIUM CHLORIDE TABLET 785
See all common drugs associated with INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS

INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 LUMACAFTOR AND IVACAFTOR 1462 0.1712
1 AZTREONAM 851 0.1180
2 DORNASE ALFA 2316 0.1180
3 PANCRELIPASE LIPASE, PANCRELIPASE PROTEASE, PANCRELIPASE AMYLASE 451 0.0748
4 TOBRAMYCIN 1580 0.0670
5 ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR 823 0.0654
6 MENADIONE 8 0.0576
7 TOBRAMYCIN SOLUTION 610 0.0501
8 TOBRAMYCIN SULFATE 624 0.0497
9 COLISTIMETHATE SODIUM 76 0.0469
See all drugs enriched for association with INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS